Depression and anxiety disorders among gastroenterologic outpatients

Studies have shown that subjects with depression have altered secretion of ghrelin, a well‐characterized, a p p e t i t e ‐ s t i m u l a t i n g h o r m o n e p r o d u c e d i n gastrointestinal system. Although blood ghrelin response is diminished after meal in untreated subjects with depression, it increases after appropriate antidepressive treatment.[1,2] Moreover, gastrointestinal hormones, including leptin and ghrelin, also have systemic effects, and their metabolism is altered in certain gastrointestinal system disorders.[3]

• Publication year

  2014

• Venue

  Saudi Journal of Gastroenterology

• Publication date

  2014-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.4103/1319-3767.141702PMID 25253372PMCID 4196354
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unstimulated and glucose-stimulated ghrelin in depressed patients and controls

  2014cited by this paper
• Association of Help-seeking Behavior with Depression and Anxiety Disorders among Gastroenterological Patients in Saudi Arabia

  2014cited by this paper
• FDA drug safety communications: a narrative review and clinical considerations for older adults.

  2012cited by this paper
• Helicobacter pylori Infection and its Relationship to Metabolic Syndrome: Is it a Myth or Fact?

  2011cited by this paper
• Maprotiline induced weight gain in depressive disorder: changes in circulating ghrelin and adiponectin levels and insulin sensitivity.

  2008cited by this paper
• Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding?

  2006cited by this paper
• Clinically Important Adverse Effects and Drug Interactions with H2‐Receptor Antagonists: An Update

  1987cited by this paper

• No citing papers are available for this paper.